Skip to main content

Table 1 Descriptive statistics of the breast cancer patients by means and standard deviations (SD), n = 56

From: Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer

Characteristics Mean (min.-max.) SD
Age at diagnosis, years 55.1 (38–69) 7.89
Education, years 15.8 (8–24) 3.47
Postmenopausal, no (%) 38 (68 %)  
Systolic BP, mmHg 132 (87–184) 22.9
Diastolic BP, mmHg 77.4 (58–108) 11.9
Height, cm 167 (155–181) 5.97
Weight, kg 70.5 (49–97) 11.6
BMI, kg/m2 25.1 (20.0–33.2) 3.48
Statin use, no (%) 3 (5 %)  
Serum lipoproteins
 Cholesterol, mmol/L 5.74 (4.00–8.00) 1.00
 HDL-cholesterol, mmol/L 1.78 (1.00–3.00) 0.49
 LDL-cholesterol, mmol/L 3.45 (1.31–5.49) 0.98
 Triglycerides, mmol/L 1.18 (0–3) 0.59
 Apolipoprotein-A, mmol/L 1.67 (1–3) 0.29
 Apolipoprotein-B, mmol/L 1.04 (0–2) 0.27
Tumor characteristics
 Tumor diameter, mm 16.4 (4–40) 8.52
 Grade 1–3 1.96 (1–3) 0.71
 Ki-67 hotspot, % 26.5 (1–81) 21.8
 Nodal metastasis, no 0,75 (0–11) 2.13
 ER positive, no (%) 52 (93 %)  
 ER percent 88,1 (0–100) 26.9
 PgR positive, no (%) 46 (82 %)  
 PgR percent 64,2 (0–100) 36.8
 Hormone receptor negative, no (%) 4 (7 %)  
 HER2 positive, no (%) 3 (5 %)  
  1. Abbreviations: BP blood pressure, BMI body mass index, ER estrogen receptor, HER2 human epidermal growth factor 2, HDL high-density lipoprotein, LDL low-density lipoprotein, PgR progesterone receptor, Ki 67 antigen Ki-67. ER positive when ≥ 1 %. PgR positive when ≥ 10 %